Coya Therapeutics, Inc. (COYA) stock
COYANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/3017% above fair value
$3.02+0.02 (+0.67%)
Close on Nov 17, 2026Market cap $70.84MP/E –Yield –
Coya Therapeutics total assets
Total assets on the balance sheet at the end of each period.
Coya Therapeutics's total assets was $39.32M at Sep 30, 2026. For fiscal 2025 it was $49.95M, up 12.6% from the year before. The highest annual figure on record is $49.95M in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $49.95M | +12.6% |
| FY2024 | Dec 31, 2024 | $44.35M | +7.5% |
| FY2023 | Dec 31, 2023 | $41.26M | +391.5% |
| FY2022 | Dec 31, 2022 | $8.40M | +75.2% |
| FY2021 | Dec 31, 2021 | $4.79M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $39.32M | +22.7% |
| Q2 FY2026 | Jun 30, 2026 | $47.31M | +41.4% |
| Q1 FY2026 | Mar 31, 2026 | $53.27M | +38.7% |
| Q4 FY2025 | Dec 31, 2025 | $49.95M | +12.6% |
| Q3 FY2025 | Sep 30, 2025 | $32.04M | -9.9% |
| Q2 FY2025 | Jun 30, 2025 | $33.45M | -16.2% |
| Q1 FY2025 | Mar 31, 2025 | $38.40M | +2.7% |
| Q4 FY2024 | Dec 31, 2024 | $44.35M | +7.5% |
| Q3 FY2024 | Sep 30, 2024 | $35.55M | +198.9% |
| Q2 FY2024 | Jun 30, 2024 | $39.94M | +176.0% |
| Q1 FY2024 | Mar 31, 2024 | $37.39M | +114.7% |
| Q4 FY2023 | Dec 31, 2023 | $41.26M | +391.5% |
| Q3 FY2023 | Sep 30, 2023 | $11.90M | +148.2% |
| Q2 FY2023 | Jun 30, 2023 | $14.47M | – |
| Q1 FY2023 | Mar 31, 2023 | $17.42M | – |
| Q4 FY2022 | Dec 31, 2022 | $8.40M | – |
| Q4 FY2021 | Dec 31, 2021 | $4.79M | – |
See a number that looks wrong?